SLC35B3 Knockout HEK293 Cell Line
Cat.No.:
EDC08070
Species:
Human
Cell Name:
HEK293
Gene:
SLC35B3
Gene ID:
51000
Size:
1×10⁶cells
SLC35B3 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08070 |
|---|---|
| Product Name | SLC35B3 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | SLC35B3 |
| NCBI Gene ID | |
| Gene Synonyms | C6orf196|CGI-19|PAPST2 |
| Summary |
This gene is a member of the solute carrier family. The encoded protein is involved in the transport of 3-prime phosphoadenosine 5-prime phosphosulfate (PAPS) from the nucleus or the cytosol to the Golgi lumen. This gene has been reported to be expressed preferentially in the human colon tissues. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC35B3 function, SLC35B3 Knockout HEK293 Cell Line or SLC35B3 overexpression HEK293 Cell Line?
The choice depends on whether you are studying SLC35B3's role as a Golgi PAPS (3'-phosphoadenosine 5'-phosphosulfate) transporter or its contributions to sulfated proteoglycan biosynthesis. The Knockout line is appropriate for asking whether SLC35B3 is required for sulfation of glycosaminoglycans and other secreted/membrane sulfated molecules. Overexpression is useful for testing PAPS transport activity in heterologous systems.
For glycosaminoglycan sulfation research, the EDITGENE SLC35B3 Knockout in HEK293 is a mechanistic platform — sulfation is essential for the biological activity of heparan sulfate, chondroitin sulfate, and other sulfated GAGs. SLC35B2 paralog expression should be assessed given functional overlap in PAPS delivery to the Golgi. Rescue with wild-type or transport-deficient SLC35B3 enables structure-function studies.
What are the application scenarios for this model?
Primary applications:
• PAPS Golgi transport: in vitro PAPS uptake assays using isolated Golgi membranes from knockout versus wild-type cells.
• Glycosaminoglycan sulfation: HPLC-based analysis of sulfated disaccharide composition in secreted GAGs to assess sulfation efficiency.
• Sulfated glycoprotein analysis: ³⁵S incorporation into newly synthesized proteoglycans and sulfated glycoproteins.
• Paralog studies: SLC35B2 expression analysis to assess PAPS transporter functional overlap.
EDITGENE recommends this model for researchers investigating PAPS transport, sulfated GAG biosynthesis, and sulfation pathway biology.
Is this SLC35B3 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. SLC35B3 rescue experiments require attention to Golgi targeting and PAPS transport mechanism:
• Construct design: use a codon-modified SLC35B3 sequence with a small C-terminal tag (FLAG, HA). Preserve transmembrane topology and Golgi targeting determinants.
• Golgi localization validation: confirm Golgi localization by GM130 co-staining before functional assays.
• Transport-deficient rescue: conserved residue mutations in PAPS-binding sites enable structure-function studies.
• Functional readout: rescue should restore Golgi PAPS uptake (in vitro membrane assays) and downstream sulfation of GAGs and sulfated glycoproteins.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download